Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome

Autor: Jean-Michel Oppert, Eric Bieth, Laurence Cuisset, Jean-Marc Lacorte, Virginie Laurier, Muriel Coupaye, Maithé Tauber, Karine Clément, Christine Poitou
Rok vydání: 2016
Předmět:
Adult
Male
0301 basic medicine
congenital
hereditary
and neonatal diseases and abnormalities

medicine.medical_specialty
Adolescent
Genotype
Endocrinology
Diabetes and Metabolism

Clinical Biochemistry
030209 endocrinology & metabolism
Context (language use)
Biology
Biochemistry
Body Mass Index
Cohort Studies
Young Adult
03 medical and health sciences
chemistry.chemical_compound
Absorptiometry
Photon

0302 clinical medicine
Endocrinology
Internal medicine
Adipocyte
Adipocytes
medicine
Humans
Resting energy expenditure
Adiposity
Chromosomes
Human
Pair 15

Biochemistry (medical)
nutritional and metabolic diseases
Middle Aged
Uniparental Disomy
medicine.disease
Obesity
Uniparental disomy
Phenotype
030104 developmental biology
chemistry
Growth Hormone
Female
Ghrelin
Chromosome Deletion
Prader-Willi Syndrome
Body mass index
Zdroj: The Journal of Clinical Endocrinology & Metabolism. 101:4895-4903
ISSN: 1945-7197
0021-972X
Popis: Adults with Prader-Willi syndrome (PWS) have an increased proportion of sc fat mass compared with body mass index (BMI)-matched controls, but whether the genotype influences body composition and metabolic profile remains controversial.To assess body composition and metabolic features in adults with PWS, according to genetic subtype. In addition, the effect of previous GH treatment was assessed. Main Outcomes and Measures: Body composition (Dual Energy X-ray Absorptiometry) and metabolic parameters were compared in PWS adults (mean age, 25.5 ± 8.9 y) with deletion (n = 47) or uniparental disomy (UPD) (n = 26), taking into account GH treatment in childhood and/or adolescence. In subgroups, adipocyte size, fasting total ghrelin levels, and resting energy expenditure were measured, and hyperphagia was assessed by the Dykens Hyperphagia Questionnaire.Body composition (Dual Energy X-ray Absorptiometry) and metabolic parameters were compared in PWS adults (mean age, 25.5 ± 8.9 y) with deletion (n = 47) or uniparental disomy (UPD) (n = 26), taking into account GH treatment in childhood and/or adolescence. In subgroups, adipocyte size, fasting total ghrelin levels, and resting energy expenditure were measured, and hyperphagia was assessed by the Dykens Hyperphagia Questionnaire.In the whole sample, the deletion group had a higher BMI compared with UPD (40.9 ± 11.5 vs 34.6 ± 9.6 kg/mA deletion genotype in adults with PWS is associated with increased BMI. GH treatment in childhood and/or adolescence limits this deleterious phenotypic effect with improved adiposity markers. This study suggests relationships between the molecular phenotype of PWS and adipose tissue development as well as sensitivity to GH.
Databáze: OpenAIRE